Trade Mark Journal No.2026/019 8 May 2026
UK00004374051 16 April 2026 (5)

- Class 5
- Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders.
AbbVie Biotechnology Ltd
Representative: Baker & McKenzie LLP